PANMRA-24-P-0000_005879 AI for Infectious Disease Threats
General Information
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Oct 03, 2024 08:26 am EDT
- Original Response Date: Oct 18, 2024 10:00 am EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Nov 02, 2024
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance: Silver Spring , MD 20910USA
Description
THIS IS A NOITICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPSALS.
The Experimental Therapeutics (ET) Branch would like to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract for Artificial Intelligence (AI)/Machine-Learning (ML) in silico screening of candidate drug compounds against known targets of infectious disease threats of interest. In their own facilities, the contractor will screen multimillions of approved and novel compounds against multiple targets to be identified by the Government to identify and develop drug-like ligands. The contractor will utilize ML decision tree algorithms for potent compound identification followed by evaluation of potential toxicity, off-target effects and potential structure based metabolic liabilities.
Attachments/Links
Contact Information
Contracting Office Address
- 808 SCHREIDER ST
- FORT DETRICK , MD 21702
- USA
Primary Point of Contact
- Linda Hinson
- linda.t.hinson.civ@health.mil
Secondary Point of Contact
- Sharew Hailu
- sharew.hailu.civ@health.mil
History
- Nov 02, 2024 11:55 pm EDTSpecial Notice (Original)
- Oct 02, 2024 12:00 am EDTSources Sought (Original)